These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 37662901)

  • 1. Initial immune response after exposure to
    Aiello A; Najafi-Fard S; Goletti D
    Front Immunol; 2023; 14():1244556. PubMed ID: 37662901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune interaction between SARS-CoV-2 and
    Booysen P; Wilkinson KA; Sheerin D; Waters R; Coussens AK; Wilkinson RJ
    Front Immunol; 2023; 14():1254206. PubMed ID: 37841282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of SARS-CoV-2 and
    Shah T; Shah Z; Yasmeen N; Baloch Z; Xia X
    Front Immunol; 2022; 13():909011. PubMed ID: 35784278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection.
    Luke E; Swafford K; Shirazi G; Venketaraman V
    Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease.
    Allué-Guardia A; Torrelles JB; Sigal A
    Front Immunol; 2023; 14():1250198. PubMed ID: 37841265
    [No Abstract]   [Full Text] [Related]  

  • 6. Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa.
    Hiemstra AM; MacDonald CE; van Rensburg IC; Stanley K; Maasdorp E; Mc Anda S; Tönsing S; Shaw JA; Tromp G; van der Spuy GD; Urdahl KB; Lewinsohn DM; Kuivaniemi H; Du Plessis N; Malherbe ST; Walzl G
    BMC Infect Dis; 2022 Apr; 22(1):381. PubMed ID: 35428268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive myeloid cells in SARS-CoV-2 and
    Shaw JA; Malherbe ST; Walzl G; du Plessis N
    Front Immunol; 2023; 14():1222911. PubMed ID: 37545508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis.
    Gopalaswamy R; Subbian S
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective interplay:
    Williams BD; Ferede D; Abdelaal HFM; Berube BJ; Podell BK; Larsen SE; Baldwin SL; Coler RN
    Front Immunol; 2024; 15():1424374. PubMed ID: 38966641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural and trained innate immunity against Mycobacterium tuberculosis.
    Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
    Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-infection of mice with SARS-CoV-2 and
    Baker PJ; Amaral EP; Castro E; Bohrer AC; Torres-Juárez F; Jordan CM; Nelson CE; Barber DL; Johnson RF; Hilligan KL; Mayer-Barber KD
    Front Immunol; 2023; 14():1240419. PubMed ID: 37720210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China.
    Li L; Zhang J; Sun R; Liu H; Cheng G; Fan F; Wang C; Li A; Liang H; Yu Z; Wang G; Ren Z
    BMC Public Health; 2024 Feb; 24(1):556. PubMed ID: 38388348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
    Najafi-Fard S; Aiello A; Navarra A; Cuzzi G; Vanini V; Migliori GB; Gualano G; Cerva C; Grifoni A; Sette A; Vaia F; Palmieri F; Goletti D
    Int J Infect Dis; 2023 May; 130 Suppl 1():S34-S42. PubMed ID: 36944383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of TB/COVID-19 Co-Infection: The phantom menace.
    Mousquer GT; Peres A; Fiegenbaum M
    Tuberculosis (Edinb); 2021 Jan; 126():102020. PubMed ID: 33246269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COVID-19 and TB syndemic: the way forward.
    Trajman A; Felker I; Alves LC; Coutinho I; Osman M; Meehan SA; Singh UB; Schwartz Y
    Int J Tuberc Lung Dis; 2022 Aug; 26(8):710-719. PubMed ID: 35898126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 27.